This, in turn, increases the numbers of L-cells, other intestinal secretory lineages, and GLP-1 secretion in both intestinal organoids and mice fed with normal chow and high-fat diet
Keep checking back, because we will keep updating this chart based on the lasts research findings and FDA Approvals
So, in sort of the bariatric endoscopy and bariatric surgery realm, we advocate for more of a combined approach. That could include bariatric surgery or endoscopy followed by a short course of GLP-1 medications
as of May 2026 is clinical trial enrollment FDA-approved alternatives exist (semaglutide, tirzepatide) with established compounding and dosing pathways and substantial clinical data Self-sourcing research peptides for human use is not safe and carries identity, purity, and contamination risks If you are a clinician: Patient questions about retatrutide source verification are increasing
This makes it a unique option for individuals experiencing decreased libido or difficulty with sexual function